Protalix Biotherapeutics, Inc.(NYSE Amex Equities : PLX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Services » Servicestothe Health Industry
|DGX||Quest Diagnostics, Inc.||-0.33%||153.01||4.7%||$189.20m|
|LH||Laboratory Corp. of America Holdings||-0.19%||296.18||2.4%||$171.78m|
|IQV||IQVIA Holdings, Inc.||-0.16%||261.86||0.0%||$147.90m|
|AMEH||Apollo Medical Holdings, Inc.||-0.78%||95.62||0.0%||$94.15m|
|PLX||Protalix Biotherapeutics, Inc.||-4.38%||1.31||18.5%||$1.70m|
|NRC||National Research Corp.||-1.35%||45.16||0.0%||$1.10m|
|QIPT||Quipt Home Medical Corp.||-1.17%||5.90||0.0%||$0.37m|
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.